Nevelsteen A, Kutten M, Lacroix H, Suy R
Department of Vascular Surgery, U.Z. Gasthuisberg, Leuven, Belgium.
Acta Chir Belg. 1992 Jan-Feb;92(1):33-6.
The authors describe three patients who developed a blue toe syndrome after initiation of oral anticoagulant therapy. Based on these observations and data in the literature, they discuss a possible relationship. They conclude that the vascular surgeon should be aware of this possibility and that oral anticoagulants should be used very carefully in the "medical" management of cholesterol embolization.
作者描述了三名在开始口服抗凝治疗后出现蓝趾综合征的患者。基于这些观察结果及文献中的数据，他们讨论了一种可能的关联。他们得出结论，血管外科医生应意识到这种可能性，并且在胆固醇栓塞的“药物”治疗中应非常谨慎地使用口服抗凝剂。
